Dr. Reddy’s Issues a Nationwide Recall of Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL, in the U.S., Due to Mislabeling of Infusion Bag
- Date
- Mar 13, 2025
- Company
- Dr. Reddy’s Laboratories Ltd.
- Brand
- Dr. Reddy’s
- Product
- Levetiracetam in Sodium Chloride Injection
- Reason
- Mislabeling of infusion bag
- Hazard
- Other
- Source
- FDA
How to identify the product
- Reddy's”), is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg/100 mL (10 mg/mL) single-dose infusion bags to the consumer level, in the United States.
- Identification information such as lot number, expiration date and NDC is presented in the table below.
- The batch was distributed nationwide between November 4, 2024, and November 6, 2024, to wholesalers.
- Reddy's Laboratories, Inc is notifying its distributors and customers to arrange for return of any recalled product.
- Wholesalers, distributors, hospitals, and pharmacies with an existing inventory of the lot being recalled, should stop use and distribution and quarantine the product immediately for return/replacement of all recalled products.
- Wholesalers, distributors, and pharmacies that have further distributed the recalled product should notify any accounts or additional locations which may have received the recalled product from them.
Where to find the lot number or date code on your package →
Product photos are on the official FDA page.
Facts are taken from the official notice. If anything here differs from it, the official notice is correct.